Cardiovascular Diseases The Cost-effectiveness of a uniform versus age-dependent Cut-off for Cardiovascular Disease Prevention Screening

被引：0
|
作者：
不详
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2023年 / 28卷 / 01期
关键词：
D O I：
10.1055/a-1983-8868
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [1] The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease
    Spacirova, Zuzana
    Kaptoge, Stephen
    Garcia-Mochon, Leticia
    Rodriguez Barranco, Miguel
    Sanchez Perez, Maria Jose
    Bondonno, Nicola P.
    Tjonneland, Anne
    Weiderpass, Elisabete
    Grioni, Sara
    Espin, Jaime
    Sacerdote, Carlotta
    Schiborn, Catarina
    Masala, Giovanna
    Colorado-Yohar, Sandra M.
    Kim, Lois
    Moons, Karel G. M.
    Engstrom, Gunnar
    Schulze, Matthias B.
    Bresson, Lea
    Moreno-Iribas, Concepcion
    Epstein, David
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (07): : 1033 - 1045
  • [2] The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease
    Zuzana Špacírová
    Stephen Kaptoge
    Leticia García-Mochón
    Miguel Rodríguez Barranco
    María José Sánchez Pérez
    Nicola P. Bondonno
    Anne Tjønneland
    Elisabete Weiderpass
    Sara Grioni
    Jaime Espín
    Carlotta Sacerdote
    Catarina Schiborn
    Giovanna Masala
    Sandra M. Colorado-Yohar
    Lois Kim
    Karel G. M. Moons
    Gunnar Engström
    Matthias B. Schulze
    Léa Bresson
    Concepción Moreno-Iribas
    David Epstein
    The European Journal of Health Economics, 2023, 24 : 1033 - 1045
  • [3] Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an Age Related Cut-off?
    Laske, Roman D.
    Dreyfuss, Michael
    Stulman, Alan
    Veraguth, Dorothe
    Huber, Alexander M.
    Roeoesli, Christof
    OTOLOGY & NEUROTOLOGY, 2019, 40 (07) : 892 - 899
  • [4] Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
    Ferket, Bart S.
    Hunink, M. G. Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    HEART, 2017, 103 (07) : 491 - 499
  • [5] Cost-effectiveness of primary and secondary prevention in cardiovascular diseases
    Troche, CJ
    Tacke, J
    Hinzpeter, B
    Danner, M
    Lauterbach, KW
    EUROPEAN HEART JOURNAL, 1998, 19 : C59 - C65
  • [6] COST-EFFECTIVENESS OF NOVEL DRUGS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Silbernagel, Gunther
    Bilger, Marcel
    ATHEROSCLEROSIS, 2024, 395
  • [7] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [8] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [9] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    CIRCULATION, 2004, 110 (17) : 802 - 802
  • [10] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
12345